Subscribe
e.g. organoids

Cassava Sciences Announces Positive Top-Line Clinical Results in Phase II Study Evaluating Simufilam in Alzheimer’s Disease

Cassava Sciences, Inc. announced positive top-line Phase II results for simufilam, its oral drug candidate for Alzheimer’s disease dementia. The study enrolled over 200 patients with mild-to-moderate Alzheimer’s disease.
[Cassava Sciences, Inc.]
Press Release
Published In
NewslettersNeural Cell News
spot_img

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News

Immunoproteasome Inhibition Prevents Progression of Castration-Resistant Prostate Cancer

[British Journal of Cancer] The immunoproteasome subunit LMP7 was silenced by using gene knockout or inhibited by the epoxyketone inhibitor ONX 0914 in a mouse castration-resistant prostate cancer (CRPC) tumor graft model and in interferon-γ-pretreated human CRPC cell lines in vitro.
NewslettersProstate Cell News
Read more

Plasma Extracellular Vesicle circRNA Signature and Resistance to Abiraterone in Metastatic Castration-Resistant Prostate Cancer

[British Journal of Cancer] 582 mCRPC patients undergoing first-line abiraterone therapy from four institutions were sorted by three phases: discovery, training, and validation.
NewslettersProstate Cell News
Read more

WNT Pathway Mutations in Metachronous Oligometastatic Castration-Sensitive Prostate Cancer

[International Journal of Radiation Oncology*Biology*Physics] Researchers performed an international multi-institutional retrospective study of 277 men with metachronous oligometastatic castration-sensitive prostate cancer who underwent targeted DNA sequencing of their primary/metastatic tumor.
NewslettersProstate Cell News
Read more
Brought to you by